Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Menstrual induction" with Sulproston.

A I Csapo, E G Peskin, M Pulkkinen

    Prostaglandins
    |November 1, 1982
    PubMed
    Summary

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)].

    Influenza and other respiratory viruses·2024
    Same author

    Serum BDNF levels correlate with regional cortical thickness in minor depression: a pilot study.

    Scientific reports·2020
    Same author

    Placebo Controlled Introduction of Prophylactic Supplementation of Probiotics to Decrease the Incidence of Necrotizing Enterocolitis at Dhulikhel Hospital in Nepal.

    Kathmandu University medical journal (KUMJ)·2018
    Same author

    The age-dependent relationship between resting heart rate variability and functional brain connectivity.

    NeuroImage·2018
    Same author

    Respiratory syncytial virus-associated hospitalization rates in high-risk populations: an observational comparative cohort analysis.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2018
    Same author

    Management of deep infiltrating endometriosis by laparoscopic route with robotic assistance: 3-year experience.

    Journal of gynecology obstetrics and human reproduction·2017
    Same journal

    Tomoxiprole selectively inhibits cyclooxygenase-2.

    Prostaglandins·1998
    Same journal

    Urinary thromboxane B2 in cardiac transplant patients as a screening method of rejection.

    Prostaglandins·1998
    Same journal

    Occurrence of 13(S)-hydroxyoctadecadienoic acid in biological samples.

    Prostaglandins·1998
    Same journal

    Nomenclature of isoprostanes: a proposal.

    Prostaglandins·1998
    Same journal

    The isoprostanes: a perspective.

    Prostaglandins·1998
    Same journal

    Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs.

    Prostaglandins·1998
    See all related articles
    This summary is machine-generated.

    Sulproston effectively terminated early pregnancies in 92% of women, offering a safe and simple medical alternative to surgical procedures. This treatment successfully induced menstruation, with most women preferring it over surgical interventions.

    Area of Science:

    • Reproductive Medicine
    • Pharmacology
    • Gynecology

    Background:

    • Early pregnancy termination is a critical aspect of reproductive healthcare.
    • Medical management offers an alternative to surgical interventions for pregnancy termination.
    • Prostaglandin analogues have been explored for their efficacy in gynecological procedures.

    Purpose of the Study:

    • To evaluate the efficacy and safety of Sulproston for medical pregnancy termination.
    • To assess Sulproston's impact on uterine activity and hormonal profiles.
    • To determine patient preference for medical versus surgical termination.

    Main Methods:

    • Administered intramuscular Sulproston (500 micrograms x 2 doses) to 200 women with early pregnancies.
    • Monitored uterine contractions, hormonal levels (estradiol, progesterone, hCG), and clinical outcomes.
    Keywords:
    Abortifacient AgentsAbortion, Drug InducedAbortion, InducedAdnexitisAge FactorsBiologyBlood PressureContraceptionContraceptive UsageDiarrheaEndocrine SystemEndometritisEstradiolEvaluationFamily PlanningFertility Control, PostcoitalFertility Control, PostconceptionGenitaliaGenitalia, FemaleGonadotropins, ChorionicLaboratory ProceduresMenstrual RegulationMethod AcceptabilityParityPhysiologyPregnancyPregnancy, First TrimesterProgesteroneProstaglandins--administraction and dosageReproductionUltrasonicsUrogenital SystemUterine EffectsUterusVomiting

    Related Experiment Videos

  • Assessed pregnancy termination completeness, need for surgical curettage, and resumption of normal menstruation.

    • Main Results:

    • Complete pregnancy termination achieved in 92% of participants.
    • 5.5% required surgical curettage; 2.5% needed a second Sulproston treatment for retained tissue.
    • 83% of women with prior surgical experience preferred medical induction with Sulproston.
    • Normal menstruation resumed in all women within 36 days.

    Conclusions:

    • Sulproston is a safe, simple, and effective drug for medical induction of menstruation and early pregnancy termination.
    • The majority of women found Sulproston a satisfactory method, particularly those with prior surgical experiences.
    • Sulproston's mechanism involves inducing uterine contractions and compromising the fetoplacental unit.